<DOC>
	<DOCNO>NCT01061645</DOCNO>
	<brief_summary>Immunotoxins ( ITs ) , monoclonal antibody conjugate plant bacterial toxin , extensively investigate possible use anti-tumor agent although carcinoma patient minimal residual disease . Various ITs test early clinical trial recent study demonstrate anti-tumor activity IT treatment patient glioblastoma different solid tumor . Systemic treatment immunotoxins direct carefully select epithelial cell surface molecule may potential eradicate also dormant metastatic tumor cell , action independent cell proliferation . The effector moieties IT use , Pseudomonas exotoxin A ( PE ) , inhibit protein synthesis eukaryotic cell catalytic inactivation ( ribosylation ) elongation factor 2 ribosome complex .</brief_summary>
	<brief_title>Study MOC31-PE Antigen Positive Carcinomas</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<criteria>Histologically confirm epithelial carcinoma , verify positive target antigen ( EpCAM/epithelial glyco protein 2 ) accord criterion give . Tumor specimen verify positive target antibody , i.e.EGP2 positive ( MOC31 ) immunocytochemical histochemical staining . Signed write informed consent Patients clinically symptomatic central nervous system ( CNS ) involvement . Both gender , age 18 75 year old . Life expectancy least 3 month Eastern Cooperative Oncology Group ( ECOG ) Performance status 02 Adequate hematologic , renal hepatic function define : Neutrophils &gt; 1.5 x 10^9/L ; Platelets &gt; 100 x 10^9/L ; Creatinine &lt; 120 umol/L ; Total bilirubin within normal range . Liver enzymes ( ALAT ASAT &lt; 2.5 UNL : alkaline phosphatase &lt; 1.5 UNL yGT &lt; 1.5 UNL ) . Coagulation parameter ( pT , PTT ) within normal range . No medical history Hepatitis B C infection Patients must ECG abnormality Patients must HIV positive Female premenopausal patient pregnant ( must negative pregnancy test prior inclusion ) lactating . Patients must use effective contraception reproductive potential . Prior chemotherapy and/or radiation complete least 4 week prior study enrolment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>MDT DLT</keyword>
</DOC>